Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study

Authors
Publication date
1 January 2020
Publisher
'American Society of Clinical Oncology (ASCO)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:735c3aa3...
    Last time updated on 27/04/2021

    ORA - Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:735c3aa3...
    Last time updated on 13/04/2022